Warner Chilcott and Mayne file patent infringement lawsuit against Sandoz

Posted on: Mon, 19 Jan 2009 09:53:00 EST


Symbols: WCRX, SDOZY
Jan 19, 2009 (Datamonitor via COMTEX) --
WCRX | Quote | Chart | News | PowerRating -- Warner Chilcott, a specialty pharmaceutical company, has announced that one of its subsidiaries and Mayne Pharma International, a subsidiary of Hospira, have filed a lawsuit against Sandoz in the District Court of New Jersey for infringement of Mayne's US patent which covers Doryx, a tetracycline-class oral antibiotic.

The lawsuit is in response to the submission of an abbreviated new drug application to the FDA by Sandoz requesting approval to manufacture and sell generic versions of Doryx 100 and 75mg delayed-release tablets prior to the expiration in 2022 of the patent. Warner Chilcott and Mayne intend to vigorously defend the patent and pursue their legal rights.

Warner Chilcott markets and sells Doryx delayed-release tablets in 150, 100 and 75mg strengths under a licensing agreement with Mayne. Warner Chilcott previously announced the filing of similar lawsuits against each of Mutual Pharmaceutical Company, Mylan Pharmaceuticals and Impax Laboratories on December 23, 2008.

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon

For full details on Warner Chilcott Ltd Cl A (WCRX) WCRX. Warner Chilcott Ltd Cl A (WCRX) has Short Term PowerRatings at TradingMarkets. Details on Warner Chilcott Ltd Cl A (WCRX) Short Term PowerRatings is available at This Link.

For full details on (SDOZY) SDOZY. (SDOZY) has Short Term PowerRatings at TradingMarkets. Details on (SDOZY) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.